These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3612685)

  • 41. Synthesis and biological evaluation of novel 2,4,5-substituted pyrimidine derivatives for anticancer activity.
    Xie F; Zhao H; Zhao L; Lou L; Hu Y
    Bioorg Med Chem Lett; 2009 Jan; 19(1):275-8. PubMed ID: 19028425
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pyridine-substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluation.
    Ertas M; Sahin Z; Berk B; Yurttas L; Biltekin SN; Demirayak S
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700272. PubMed ID: 29522642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biochemistry and pharmacology of 7alpha-substituted androstenediones as aromatase inhibitors.
    Brueggemeier RW; O'Reilly JM; Lovely CJ; Ward PJ; Quinn AL; Baker D; Darby MV; Gu XJ; Gilbert NE
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):247-54. PubMed ID: 9365197
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors.
    Yahiaoui S; Pouget C; Fagnere C; Champavier Y; Habrioux G; Chulia AJ
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5215-8. PubMed ID: 15380230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and ++thiosangivamycin: influence of various 7-substituents on antiviral activity.
    Renau TE; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1996 Feb; 39(4):873-80. PubMed ID: 8632411
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New 7,8-benzoflavanones as potent aromatase inhibitors: synthesis and biological evaluation.
    Yahiaoui S; Fagnere C; Pouget C; Buxeraud J; Chulia AJ
    Bioorg Med Chem; 2008 Feb; 16(3):1474-80. PubMed ID: 18042388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and structure-activity relationships of 6-substituted androst-4-ene analogs as aromatase inhibitors.
    Numazawa M; Kamiyama T; Tachibana M; Oshibe M
    J Med Chem; 1996 May; 39(11):2245-52. PubMed ID: 8667367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on aromatase inhibitors. II. Synthesis and biological evaluation of 1-amino-1H-1,2,4-triazole derivatives.
    Okada M; Yoden T; Kawaminami E; Shimada Y; Kudoh M; Isomura Y
    Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):333-7. PubMed ID: 9118448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 11. Quinolylmethyl analogues with basic substituents conveying specificity.
    Davis SE; Rauckman BS; Chan JH; Roth B
    J Med Chem; 1989 Aug; 32(8):1936-42. PubMed ID: 2502633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of 3-[N-(2-chlorobenzyl)amino]-6-(1H-imidazol-1-yl) pyridazine dihydrochloride on various aromatase enzyme systems and experimental breast cancer.
    Bandoh K; Ishizuka Y; Sato M
    Arzneimittelforschung; 1995 Aug; 45(8):897-900. PubMed ID: 7575757
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 2,4-diamino-5-deaza-6-substituted pyrido[2,3-d]pyrimidine antifolates as potent and selective nonclassical inhibitors of dihydrofolate reductases.
    Gangjee A; Vasudevan A; Queener SF; Kisliuk RL
    J Med Chem; 1996 Mar; 39(7):1438-46. PubMed ID: 8691474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, structure elucidation, and biochemical evaluation of 7 alpha- and 7 beta-arylaliphatic-substituted androst-4-ene-3,17-diones as inhibitors of aromatase.
    O'Reilly JM; Li N; Duax WL; Brueggemeier RW
    J Med Chem; 1995 Jul; 38(15):2842-50. PubMed ID: 7636845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and antischistosomal activity of certain pyrazolo[1,5-a]pyrimidines.
    Senga K; Novinson T; Wilson HR; Robins RK
    J Med Chem; 1981 May; 24(5):610-3. PubMed ID: 7241518
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Research on heterocyclic compounds. XXII. Imidazo[1,2-a]pyrimidines.
    Abignente E; Arena F; Luraschi E; Saturnino C; Berrino L; De Santis D; Marmo E
    Farmaco Sci; 1987 Sep; 42(9):657-69. PubMed ID: 3500872
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and antihyperlipidemic activity of some novel condensed 2-chloroalkyl-4-chloro/hydroxy-5,6-disubstituted pyrimidines.
    Kathiravan MK; Shishoo CJ; Kumar KG; Roy SK; Mahadik KR; Kadam SS; Jain KS
    Arzneimittelforschung; 2007; 57(9):599-606. PubMed ID: 17966759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors.
    Neves MA; Dinis TC; Colombo G; Sá e Melo ML
    J Med Chem; 2009 Jan; 52(1):143-50. PubMed ID: 19072235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel synthesis of dihydropyrimidines for α-glucosidase inhibition to treat type 2 diabetes: in vitro biological evaluation and in silico docking.
    Yar M; Bajda M; Shahzadi L; Shahzad SA; Ahmed M; Ashraf M; Alam U; Khan IU; Khan AF
    Bioorg Chem; 2014 Jun; 54():96-104. PubMed ID: 24880489
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and evaluation of benzoxazolinonic imidazoles and derivatives as non-steroidal aromatase inhibitors.
    Nativelle-Serpentini C; Moslemi S; Yous S; Park CH; Lesieur D; Sourdaine P; Séralini GE
    J Enzyme Inhib Med Chem; 2004 Apr; 19(2):119-27. PubMed ID: 15449726
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and biological evaluation of 4-imidazolylflavans as nonsteroidal aromatase inhibitors.
    Pouget C; Yahiaoui S; Fagnere C; Habrioux G; Chulia AJ
    Bioorg Chem; 2004 Dec; 32(6):494-503. PubMed ID: 15530990
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
    Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
    J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.